| Combining paclitaxel with ABT-263 has a synergistic effect on paclitaxel resistant prostate cancer cells C Wang, SB Huang, MC Yang, YT Lin, IH Chu, YN Shen, YH Chiu, ... PLoS One 10 (3), e0120913, 2015 | 39 | 2015 |
| P53 enhances apoptosis induced by doxorubicin only under conditions of severe DNA damage RW Lin, CJ Ho, HW Chen, YH Pao, LE Chen, MC Yang, SB Huang, ... Cell Cycle 17 (17), 2175-2186, 2018 | 38 | 2018 |
| Bim directly antagonizes Bcl-xl in doxorubicin-induced prostate cancer cell apoptosis independently of p53 MC Yang, RW Lin, SB Huang, SY Huang, WJ Chen, S Wang, YR Hong, ... Cell Cycle 15 (3), 394-402, 2016 | 37 | 2016 |
| Wntless (GPR177) expression correlates with poor prognosis in B-cell precursor acute lymphoblastic leukemia via Wnt signaling SS Chiou, LT Wang, SB Huang, CY Chai, SN Wang, YM Liao, PC Lin, ... Carcinogenesis 35 (10), 2357-2364, 2014 | 31 | 2014 |
| Suppression of ribosomal protein RPS6KB1 by Nexrutine increases sensitivity of prostate tumors to radiation SS Hussain, SB Huang, RG Bedolla, P Rivas, JW Basler, GP Swanson, ... Cancer Letters 433, 232-241, 2018 | 21 | 2018 |
| Androgen deprivation-induced elevated nuclear SIRT1 promotes prostate tumor cell survival by reactivation of AR signaling SB Huang, D Thapa, AR Munoz, SS Hussain, X Yang, RG Bedolla, ... Cancer Letters 505, 24-36, 2021 | 15 | 2021 |
| CFS-1686 causes cell cycle arrest at intra-S phase by interference of interaction of topoisomerase 1 with DNA RW Lin, CN Yang, SY Ku, CJ Ho, SB Huang, MC Yang, HW Chang, ... PLoS One 9 (12), e113832, 2014 | 14 | 2014 |
| Attenuation of NAD [P] H: quinone oxidoreductase 1 aggravates prostate cancer and tumor cell plasticity through enhanced TGFβ signaling D Thapa, SB Huang, AR Muñoz, X Yang, RG Bedolla, CN Hung, CL Chen, ... Communications biology 3 (1), 12, 2020 | 13 | 2020 |
| SIRT1 inhibition‐induced senescence as a strategy to prevent prostate cancer progression SB Huang, P Rivas, X Yang, Z Lai, Y Chen, KL Schadler, M Hu, ... Molecular carcinogenesis 61 (7), 702-716, 2022 | 8 | 2022 |
| Evidence for 2-methoxyestradiol-mediated inhibition of receptor tyrosine kinase RON in the management of prostate cancer IS Batth, SB Huang, M Villarreal, J Gong, D Chakravarthy, B Keppler, ... International journal of molecular sciences 22 (4), 1852, 2021 | 8 | 2021 |
| Receptor tyrosine kinase recepteur d'origine nantais as predictive marker for aggressive prostate cancer in African Americans RG Bedolla, DP Shah, SB Huang, RL Reddick, R Ghosh, AP Kumar Molecular carcinogenesis 58 (6), 854-861, 2019 | 8 | 2019 |
| Cover Image, Volume 61, Issue 7 SB Huang, P Rivas, X Yang, Z Lai, Y Chen, KL Schadler, M Hu, ... Molecular Carcinogenesis 61 (7), i-i, 2022 | | 2022 |
| Intercepting ribosomal protein S6KB1 signaling: Prevention of prostate cancer recurrence AP Kumar, A Clark, M Villarreal, S Jayamohan, SB Huang, SS Hussain, ... Cancer Research 82 (12_Supplement), 4-4, 2022 | | 2022 |
| Abstract PO-085: Therapeutic targeting of RPS6KB1/SQSTM1 axis to prevent biochemical recurrence AP Kumar, A Clark, MR Villarreal, SB Huang, SS Hussain, X Yang, ... Clinical Cancer Research 27 (8_Supplement), PO-085-PO-085, 2021 | | 2021 |
| Targeting glutamine addiction in pancreatic cancer X Yang, AR Muñoz, SB Huang, M Hanes, RG Bedolla, D Chakravarthy, ... Cancer Research 79 (13_Supplement), 116-116, 2019 | | 2019 |
| SIRT1 functions as a double-edged sword in prostate cancer SB Huang, D Thapa, RG Bedolla, AR Muñoz, X Yang, P Rivas, ... Cancer Research 79 (13_Supplement), 5082-5082, 2019 | | 2019 |
| Inhibition of ribosomal protein RPS6KB1 as a strategy to improve conventional therapy for prostate cancer AD Clark, SS Hussain, SB Huang, RG Bedolla, MA Obeidat, ... Cancer Research 79 (13_Supplement), 3943-3943, 2019 | | 2019 |
| Palmatine as a potential pancreatic cancer therapeutic agent AR Muñoz, R Bedolla, SB Huang, X Yang, P Rivas, R Reddick, M Hanes, ... Cancer Research 78 (13_Supplement), 5823-5823, 2018 | | 2018 |
| Novel role for SIRT1 in non-canonical activation of AR signaling SB Huang, D Thapa, A Muñoz, RG Bedolla, R Srivastav, R Ghosh, ... Cancer Research 78 (13_Supplement), 945-945, 2018 | | 2018 |
| Non-canonical activation of AR signaling by histone deacetylase SIRT1 SB Huang, D Thapa, SS Hussain, RG Bedolla, G Li, RL Reddick, Z Lai, ... Cancer Research 77 (13_Supplement), 3521-3521, 2017 | | 2017 |
Hiroshi MiyamotoUniversity of Rochester Medical Center在 urmc.rochester.edu 的电子邮件经过验证
